Philips has received FDA approval.
The company announced that the FDA has granted approval forPhilips MRCAT system with artificial intelligence support. Device manufacturers have registered and notified the FDA of their intention to sell a medical device at least 90 days in advance, as required by the agency.
The MRCAT system allows the use of MRI inas a primary imaging modality without the need for oncologists to use computed tomography. The AI software creates images that look like those obtained with a CT scan in terms of accuracy and resolution. MRCAT operation takes less than three minutes.
Combining AI with other features
AI-enabled MRCAT allows MRI or magnetic resonance imaging to be used as the primary imaging modality when using radiation therapy to treat tumors in the head or neck.
According to an official statement from the company, they strive to ensure that MRI diagnostics is comfortable for patients, and also provides oncologists with accurate images of difficult-to-treat tumors.
Read more:
Starlink signal hacked to be used as an alternative to GPS
NASA revealed the origin of Haumea - the most mysterious planet in the solar system
Physicists Break Standard Quantum Limit With 'Quantum Horror'